Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

JANSSEN PHARMACEUTICALS, INC.

Subsidiary ofJOHNSON & JOHNSONUEI: J319ZWMD2114CAGE: 5AJ94

JANSSEN PHARMACEUTICALS, INC. is a federal contractor, registered under UEI J319ZWMD2114 and CAGE code 5AJ94. It has been awarded $1,536,517 in federal contracts. Primary work spans Medicinal and Botanical Manufacturing and Drugs and Druggists' Sundries Merchant Wholesalers. Top awarding agencies include Department Of Defense.

Contact Information

Registration and classification details

Registration

UEI Code

J319ZWMD2114

CAGE Code

5AJ94

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationManufacturer of Goods

NAICS Codes

325412Pharmaceutical Preparation Manufacturing(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

Janssen Pharmaceuticals, Inc. specializes in the manufacturing of pharmaceutical preparations and medicinal substances, with technical expertise in the production of active pharmaceutical ingredients, sterile formulations, and hematology-related therapeutics. The company operates under strict cGMP s...

Janssen Pharmaceuticals, Inc. specializes in the manufacturing of pharmaceutical preparations and medicinal substances, with technical expertise in the production of active pharmaceutical ingredients, sterile formulations, and hematology-related therapeutics. The company operates under strict cGMP standards to ensure batch consistency, regulatory compliance, and supply chain integrity for mission-critical drug products. Their capabilities include end-to-end manufacturing processes—from synthesis and purification to final packaging—tailored for government use, particularly in areas requiring high-purity compounds and controlled distribution. Specialization in hematology-focused pharmaceuticals and branded pharmaceutical distribution indicates a focused approach to complex therapeutic categories requiring stringent quality control and cold-chain logistics. The contractor has delivered products to the Department of Veterans Affairs and the Department of Defense, supporting clinical and operational needs through direct supply of FDA-regulated pharmaceuticals. For the VA, this includes fulfillment under Federal Supply Schedule contracts for drugs used in chronic disease management and hematologic conditions. For the DoD, manufacturing and distribution services support military medical readiness, including deployment-ready therapeutics and specialty pharmaceuticals for battlefield medicine and long-term care. Janssen’s primary industry focus is on NAICS 325412 (Pharmaceutical Preparation Manufacturing) and 325411 (Medicinal and Botanical Manufacturing), positioning them as a niche supplier of precision-manufactured drugs for government health and defense systems. Their work emphasizes compliance with USP, FDA, and DOD specifications for drug stability, labeling, and traceability, serving a highly regulated vertical where product integrity is non-negotiable. As a 2L entity headquartered in Titusville, New Jersey, Janssen Pharmaceuticals operates as a mid-sized manufacturer with deep infrastructure for pharmaceutical production. While no government certifications are listed, their consistent award history reflects demonstrated reliability in meeting federal procurement standards for pharmaceutical quality and delivery. Their geographic presence in a major biopharmaceutical hub enhances access to skilled labor, regulatory resources, and logistics networks critical for government supply chain operations.

Key Performance Metrics

Awards Count

172

All time

Active

1

Currently performing

Completed

171

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with JANSSEN PHARMACEUTICALS, INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for JANSSEN PHARMACEUTICALS, INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in JANSSEN PHARMACEUTICALS, INC.'s top NAICS codes and agencies

NAICS: 541330
New
Federal
Army Contracting Command – Red River Army Depot (ACC-RRAD) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)
Solicitation # W911RQ-27-S-C001
The Army Contracting Command – Red River Army Depot (ACC-RRAD) has issued Commercial Solutions Opening (CSO) W911RQ-27-S-C001 to modernize its Organic Industrial Base (OIB). This initiative focuses on Convergent Manufacturing, seeking innovative commercial items, technologies, and services in areas such as digital twins, automation, cyber security, and agile facilities to enhance the Defense Manufacturing Base. The CSO utilizes a streamlined acquisition process authorized by DFARS Subpart 212-70, allowing both traditional and non-traditional defense contractors to compete for FAR Part 12 commercial item contracts. The overall solicitation remains open until September 30, 2027, with a general period of performance for awarded solutions typically not exceeding 12 months. The procurement is executed through specific Areas of Interest (AoIs), which have included requirements for micro trucks, industrial parts washer leasing and maintenance, and fire suppression system repairs for Building 431. The evaluation process is conducted in three phases: an initial solution brief, a presentation or pitch, and a final Commercial Solutions Proposal. Technical evaluations prioritize responsiveness to the AoI, technical merit, and innovation, while price proposals must be determined as fair and reasonable. Awardees must be registered in the System for Award Management (SAM) and possess a Unique Entity ID. Specific project requirements may include strict adherence to military marking standards, environmental liability insurance, and certification by registered professional engineers.
Department Of Defense

POSTED

1 day ago

DEADLINE

in 12 months
View Details
NAICS: 424210
New
SLED
Purchase of Antibiotics
Solicitation # 2026-Informal-0210
The City of Pasadena Public Health Department is seeking a qualified vendor for a one-time purchase of FDA-approved antibiotics to be stockpiled for city staff and their dependents. This procurement is intended to ensure rapid availability of medication following exposure to Category A agents, specifically anthrax, plague, or tularemia. The required deliverables include 30,000 tablets of Ciprofloxacin (500mg/dose) and 200,000 tablets of Doxycycline Hyclate/Monohydrate (100mg/dose). The purchase must be completed within the city's fiscal year ending June 30, 2027, with a strict delivery requirement of four business days from the time of order to the facility at 1845 N Fair Oaks Ave, Pasadena, CA. Vendors must adhere to rigorous CDC and industry standards for storage and handling, including cold-chain requirements and the use of temperature-monitoring devices during transit. Full lot-level traceability from production to distribution is mandatory, and all products must be accurately labeled with lot numbers, expiration dates, and manufacturer details. Bidders must be registered in SAM.gov with a Unique Entity ID and provide a Pasadena Business License. The selection process is an informal solicitation requiring electronic pricing submission via the City's eProcurement Portal by October 28, 2026. Award eligibility is contingent upon meeting insurance requirements, agreeing to Net 30 payment terms, and complying with federal regulations including the Buy America Requirement and the Davis-Bacon Act.
Public Health Department

POSTED

5 days ago

DEADLINE

in 8 days
View Details
NAICS: 424210
New
DIBBS
REHYDRATION SALTS FOR
Solicitation # SPE2DP-27-T-0116
Solicitation SPE2DP-27-T-0116 is issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of lemon flavored electrolyte oral rehydration powder, identified by NSN 6505016462692. The requirement is for two packages, with each package containing 100 packets of 21 grams each. Each prepared packet provides a specific electrolyte composition consisting of 665 mg of sodium, 390 mg of potassium, 80 mg of citrate, 83 mg of magnesium, and 3 mg of zinc when mixed into 16.9 fl oz of solution. The item is an over-the-counter product with a non-extendable shelf life of 24 months. Delivery is required within 20 days after receipt of order, with an original required delivery date of October 19, 2026. The shipping terms are FOB Destination, with the final delivery point being the USNS CODY T-EPF-14. Packaging must be commercial and compliant with ASTM D3951 for non-hazardous materials or TQ requirement IP025 for hazardous materials, while marking must adhere to Medical Marking Standard No. 1. Inspection and acceptance will occur at the destination. Payment and receiving reports must be processed electronically through the Wide Area WorkFlow system. The solicitation is associated with NAICS code 424210 and incorporates various FAR and DFARS clauses, including the Buy American and Balance of Payments Program and requirements for safeguarding covered defense information.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

5 days ago

DEADLINE

in 1 day
View Details
NAICS: 541330
New
Federal
AIR FORCE CRYPTOLOGIC OFFICE COMMERCIAL SOLUTIONS OPENING
Solicitation # FA7037-21-S-C001
The Air Force Cryptologic Office Cyberspace Intelligence Surveillance and Reconnaissance and Multi-Domain Innovation Division is soliciting innovative commercial capabilities through Commercial Solutions Opening FA7037-21-S-C001. The agency is seeking mature technologies and services in Electromagnetic Warfare, Information Operations, and electromagnetic digital communications, with a specific goal of achieving a field demonstration within one year. This effort emphasizes the use of novel material approaches and innovative services, including a recent update to incorporate Super Intelligence. Awards may be issued as contracts or Other Transactions with periods of performance typically ranging from one to five years. The procurement follows a competitive two-phase submission process governed by 10 USC 3458 and DFARS 212.70. Phase I requires the submission of Quad Charts and White Papers, which are evaluated based on technical merit, importance to the AFCO mission, and fund availability. Offerors who are determined to be technically qualified may be invited to submit full Phase II proposals, including a detailed Statement of Work and a price proposal. All submissions are treated as commercial items, and offerors must possess the necessary personnel and facility security clearances to handle classified work in accordance with the National Industrial Security Program Operating Manual.
Department Of Defense

POSTED

5 days ago

DEADLINE

in 11 months
View Details